154 related articles for article (PubMed ID: 15339676)
1. Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia.
Venditti A; Del Poeta G; Maurillo L; Buccisano F; Del Principe MI; Mazzone C; Tamburini A; Cox C; Panetta P; Neri B; Ottaviani L; Amadori S
Haematologica; 2004 Aug; 89(8):934-9. PubMed ID: 15339676
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
[TBL] [Abstract][Full Text] [Related]
3. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.
Tóthová E; Fricova M; Stecová N; Kafková A; Elbertová A
Neoplasma; 2002; 49(3):141-4. PubMed ID: 12097997
[TBL] [Abstract][Full Text] [Related]
4. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
5. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
7. [Relation between Bcl-2 protein expression and results of therapy in patients with acute myeloblastic leukemia].
Tóthová E; Stecová N; Kafková A; Fricová M; Guman T; Elbertová A
Vnitr Lek; 2004 Feb; 50(2):139-42. PubMed ID: 15077589
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
[TBL] [Abstract][Full Text] [Related]
9. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.
van Stijn A; van der Pol MA; Kok A; Bontje PM; Roemen GM; Beelen RH; Ossenkoppele GJ; Schuurhuis GJ
Haematologica; 2003 May; 88(5):497-508. PubMed ID: 12745269
[TBL] [Abstract][Full Text] [Related]
10. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
Suárez L; Vidriales MB; Moreno MJ; López A; García-Laraña J; Pérez-López C; Tormo M; Lavilla E; López-Berges MC; de Santiago M; San Miguel JF; Orfao A;
Haematologica; 2005 Jan; 90(1):54-9. PubMed ID: 15642669
[TBL] [Abstract][Full Text] [Related]
11. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
13. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
[TBL] [Abstract][Full Text] [Related]
14. Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.
Schaich M; Harbich-Brutscher E; Pascheberg U; Mohr B; Soucek S; Ehninger G; Illmer T
Haematologica; 2002 May; 87(5):455-64. PubMed ID: 12010657
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia.
Maynadié M; Gerland L; Aho S; Girodon F; Bernier M; Brunet C; Campos L; Daliphard S; Deneys V; Falkenrodt A; Jacob MC; Kühlein E; LeCalvez G; Moskovtchenko P; Philip P; Carli PM; Faure GC; Béné MC;
Haematologica; 2002 Aug; 87(8):795-803. PubMed ID: 12161354
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients.
Daneshbod Y; Amirghofran Z; Tabei SZ
Neoplasma; 2005; 52(2):109-14. PubMed ID: 15800708
[TBL] [Abstract][Full Text] [Related]
17. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
Orfao A; Chillón MC; Bortoluci AM; López-Berges MC; García-Sanz R; Gonzalez M; Tabernero MD; García-Marcos MA; Rasillo AI; Hernández-Rivas J; San Miguel JF
Haematologica; 1999 May; 84(5):405-12. PubMed ID: 10329918
[TBL] [Abstract][Full Text] [Related]
18. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
19. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
[TBL] [Abstract][Full Text] [Related]
20. Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients.
Perea G; Domingo A; Villamor N; Palacios C; Juncà J; Torres P; Llorente A; Fernández C; Tormo M; Queipo de Llano MP; Bargay J; Gallart M; Florensa L; Vivancos P; Martí JM; Font L; Berlanga J; Esteve J; Bueno J; Ribera JM; Brunet S; Sierra J; Nomdedéu JF;
Leuk Res; 2005 Oct; 29(10):1109-16. PubMed ID: 16095690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
